BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 36718538)

  • 1. Targeting critical pathways in ferroptosis and enhancing antitumor therapy of Platinum drugs for colorectal cancer.
    Wang G; Wang JJ; Zhi-Min Z; Xu XN; Shi F; Fu XL
    Sci Prog; 2023; 106(1):368504221147173. PubMed ID: 36718538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppressing the KIF20A/NUAK1/Nrf2/GPX4 signaling pathway induces ferroptosis and enhances the sensitivity of colorectal cancer to oxaliplatin.
    Yang C; Zhang Y; Lin S; Liu Y; Li W
    Aging (Albany NY); 2021 Mar; 13(10):13515-13534. PubMed ID: 33819186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro siRNA-mediated GPX4 and AKT1 silencing in oxaliplatin resistance cancer cells induces ferroptosis and apoptosis.
    Golbashirzadeh M; Heidari HR; Aghamolayi AA; Fattahi Y; Talebi M; Khosroushahi AY
    Med Oncol; 2023 Aug; 40(10):279. PubMed ID: 37632628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nrf2 inhibition increases sensitivity to chemotherapy of colorectal cancer by promoting ferroptosis and pyroptosis.
    Huang Y; Yang W; Yang L; Wang T; Li C; Yu J; Zhang P; Yin Y; Li R; Tao K
    Sci Rep; 2023 Sep; 13(1):14359. PubMed ID: 37658132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of Nrf2 inhibits ferroptosis and protects against oxaliplatin-induced ototoxicity.
    Xu K; Chang X; Bai X; Liu HB; Chen XB; Chen HP; Liu YH
    Biomed Pharmacother; 2023 Sep; 165():115248. PubMed ID: 37523980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxaliplatin induces ferroptosis and oxidative stress in HT29 colorectal cancer cells by inhibiting the Nrf2 signaling pathway.
    Liu B; Wang H
    Exp Ther Med; 2022 Jun; 23(6):394. PubMed ID: 35495610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tagitinin C induces ferroptosis through PERK-Nrf2-HO-1 signaling pathway in colorectal cancer cells.
    Wei R; Zhao Y; Wang J; Yang X; Li S; Wang Y; Yang X; Fei J; Hao X; Zhao Y; Gui L; Ding X
    Int J Biol Sci; 2021; 17(11):2703-2717. PubMed ID: 34345202
    [No Abstract]   [Full Text] [Related]  

  • 8. Non-canonical role of UCKL1 on ferroptosis defence in colorectal cancer.
    Wu W; Zhao Y; Qin B; Jiang X; Wang C; Hu R; Ma R; Lee MH; Liu H; Li K; Yuan P
    EBioMedicine; 2023 Jul; 93():104650. PubMed ID: 37343364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer.
    Shin D; Kim EH; Lee J; Roh JL
    Free Radic Biol Med; 2018 Dec; 129():454-462. PubMed ID: 30339884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of CDK1 Overcomes Oxaliplatin Resistance by Regulating ACSL4-mediated Ferroptosis in Colorectal Cancer.
    Zeng K; Li W; Wang Y; Zhang Z; Zhang L; Zhang W; Xing Y; Zhou C
    Adv Sci (Weinh); 2023 Sep; 10(25):e2301088. PubMed ID: 37428466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of resistance to oxaliplatin by vorinostat in human colorectal cancer cells through inhibition of Nrf2 nuclear translocation.
    Tanaka S; Hosokawa M; Tatsumi A; Asaumi S; Imai R; Ogawara KI
    Biochem Biophys Res Commun; 2022 Jun; 607():9-14. PubMed ID: 35358872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ibrutinib facilitates the sensitivity of colorectal cancer cells to ferroptosis through BTK/NRF2 pathway.
    Zhu JF; Liu Y; Li WT; Li MH; Zhen CH; Sun PW; Chen JX; Wu WH; Zeng W
    Cell Death Dis; 2023 Feb; 14(2):151. PubMed ID: 36823108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOXA2 Suppression by TRIM36 Exerts Anti-Tumor Role in Colorectal Cancer Via Inducing NRF2/GPX4-Regulated Ferroptosis.
    Liu X; Yan C; Chang C; Meng F; Shen W; Wang S; Zhang Y
    Adv Sci (Weinh); 2023 Dec; 10(35):e2304521. PubMed ID: 37875418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ferroptosis: regulation by competition between NRF2 and BACH1 and propagation of the death signal.
    Nishizawa H; Yamanaka M; Igarashi K
    FEBS J; 2023 Apr; 290(7):1688-1704. PubMed ID: 35107212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of SRSF9 enhances the sensitivity of colorectal cancer to erastin-induced ferroptosis by reducing glutathione peroxidase 4 expression.
    Wang R; Su Q; Yin H; Wu D; Lv C; Yan Z
    Int J Biochem Cell Biol; 2021 May; 134():105948. PubMed ID: 33609745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights on Ferroptosis and Colorectal Cancer: Progress and Updates.
    Hu B; Yin Y; Li S; Guo X
    Molecules; 2022 Dec; 28(1):. PubMed ID: 36615434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketogenesis attenuated KLF5 disrupts iron homeostasis via LIF to confer oxaliplatin vulnerability in colorectal cancer.
    Jiang H; Zeng Y; Jiang X; Xu X; Zhao L; Yuan X; Xu J; Zhao M; Wu F; Li G
    Biochim Biophys Acta Mol Basis Dis; 2024 Aug; 1870(6):167210. PubMed ID: 38704001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dihydromyricetin reverses MRP2-induced multidrug resistance by preventing NF-κB-Nrf2 signaling in colorectal cancer cell.
    Wang Z; Sun X; Feng Y; Wang Y; Zhang L; Wang Y; Fang Z; Azami NLB; Sun M; Li Q
    Phytomedicine; 2021 Feb; 82():153414. PubMed ID: 33461143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adipocyte-Derived Exosomal MTTP Suppresses Ferroptosis and Promotes Chemoresistance in Colorectal Cancer.
    Zhang Q; Deng T; Zhang H; Zuo D; Zhu Q; Bai M; Liu R; Ning T; Zhang L; Yu Z; Zhang H; Ba Y
    Adv Sci (Weinh); 2022 Oct; 9(28):e2203357. PubMed ID: 35978266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis.
    Roh JL; Kim EH; Jang H; Shin D
    Redox Biol; 2017 Apr; 11():254-262. PubMed ID: 28012440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.